Abstract
Previous studies have indicated that the patients with psychiatric illness were at higher risk of hepatitis B virus (HBV) infection. However, the efficacy of hepatitis B vaccine in schizophrenia patients remains unclear. Between June 2014 and January 2015, 415 schizophrenia patients and 3,038 controls who had been routinely immunized as infants were recruited in the present study. Hepatitis B surface antigen (HBsAg), HBsAb, and HBV DNA were detected with commercial methods according to the manufacturer's protocol. A 600-bp region of the S gene (region nt236-nt835) was amplified by nested polymerase chain reaction (PCR). The genotypes of isolated HBV were identified using phylogenetic analysis by the neighbor-joining algorithm in the software MEGA version 4.1. The seroprevalence of HBsAg in schizophrenia patients was 6.75%, which was significantly higher than 3.32% measured in controls. HBsAg prevalence was 7.94% in male schizophrenia patients and 5.47% in female schizophrenia patients, while it was only 4.04% in males and 2.08% in females in the control group. The HBsAb seroprevalence rate was 58.31% in schizophrenia patients and 59.94% in non-schizophrenia controls. Moreover, one HBV strain in the schizophrenia group presented I126S vaccine escape mutation (5.88%), while three HBV isolates showed Q129H, M133L, and G145R vaccine escape mutations in the control group (6.81%). Schizophrenia patients are at higher risk for HBV infection, even those who had received routine immunization. Therefore, a booster HB vaccination targeted at schizophrenia patients should be considered in the future.
Highlights
Previous studies have indicated that the patients with psychiatric illness were at higher risk of hepatitis B virus (HBV) infection
415 schizophrenia patients (214 males and 201 females), between 16 and 20 years of age, and 3,038 general controls (1,932 males and 1,106 females), between 16 and 20 years of age, with complete HB vaccination records were recruited in the present study
Discussion we reported that the prevalence of Hepatitis B surface antigen (HBsAg) was 6.75% in vaccinated schizophrenia patients, which was significantly higher than that detected in controls (3.32%) and vaccinated children (2.08%) in China
Summary
Previous studies have indicated that the patients with psychiatric illness were at higher risk of hepatitis B virus (HBV) infection. In order to control HBV infection in China, the national expanded vaccination program was launched in 1992. It has had a dramatic impact on the reduction of HBV infection and is estimated to have prevented over four million deaths [5,6], especially in children and adolescents. Epidemiological studies revealed that some specific groups might be at higher risk for HBV infection, including patients undergoing dialysis, parenteral drug users, immunosuppressed patients, male homosexuals, and those suffering serious mental illness [7,8,9]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
